Altavo raised €3.0M in a Series A round in Jan 2026. The company is based in Dresden, Germany. Investors in the round: bm-t Beteiligungsmanagement Thüringen GmbH, High-Tech Gründerfonds (HTGF), Novalis Biotech and 3 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €3.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
